Compositions and methods for stabilizing liposomal drug formulations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090285878A1
SERIAL NO

11667138

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to liposomal compositions comprising a camptothecin, which are optimized to reduce camptothecin degradation and/or precipitation of camptothecin degradation products in the external medium. The invention further provides improved methods of formulating liposomal camptothecins, kits comprising liposome-encapsulated camptothecins, and methods of using the same to treat a variety of diseases and disorders, including cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TEKMIRA PHARMACEUTICALS CORPORATION8900 GLENLYON PARKWAY BURNABY V5J 5J8

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hope, Michael J Vancouver , CA 56 3601
Madden, Thomas D Vancouver , CA 41 2383
Mui, Barbara Vancouver , CA 18 645

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation